Search Results 121-130 of 15850 for pharmacogenetics
As genetic sequencing has become faster and cheaper, more people are considering predictive genetic testing to identify their future risk for disease, with the ...
About this study. This ComboMATCH patient registration trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by ...
On Saturday, Oct. 5, we will broadcast from the Individualizing Medicine Conference, in Rochester, Minn. We'll discuss how the promise of genomic medicine has ...
The study, which implicates the genes EPHA5, ARHGEF10, and PRX, is the first to mine large swaths of the human genome for predictors of chemotherapy side ...
Some people with cancer may have aquired their disease because they inherited an abnormal (mutated) gene. The researchers of this study want to better ...
Pharmacogenetics and novel pharmacotherapeutics. A major focus of Dr. Camilleri's lab is the development and testing of new medications for all the ...
Propionic acidemia (PA) is a metabolic genetic disease that occurs in 1 in 35,000 live births in the United States. This disease causes metabolic acidosis, ...
This study will help the investigator determine whether certain genetic mutations, more than others, are a cause of more severe disease in Dent Disease.
Two Mayo Clinic Ph.D. candidates are exploring how artificial intelligence (AI) can be used to make these alerts more actionable and less intrusive for ...
Mayo Clinic physicians are committed to collaborating with referring physicians. Telephone consultations and referrals may be arranged by contacting the ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.